Wednesday, March 29, 2017

British Journal of Cancer - Table of Contents alert Volume 116 Issue 7

If you are unable to see the message below, click here to view.
British Journal of Cancer

TABLE OF CONTENTS

Volume 116, Issue 7 (841-971)
Published online 28 March 2017

In this issue
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Epidemiology

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
 
Advertisement
BACR 2017 Conferences
The BACR hosts a number of specialist cancer meetings to bring together the latest thinking in cancer research. Having links with organisations such as EACR,NCRI and RSM boosts opportunities for networking and establishing collaborations with leaders in cancer research.
Interested in attending/or presenting then visit www.bacr.org.uk/events
 

Minireview

Top

Study designs may influence results: the problems with questionnaire-based case–control studies on the epidemiology of glioma

Christoffer Johansen, Joachim Schüz, Anne-Marie Serena Andreasen and Susanne Oksbjerg Dalton

Br J Cancer 2017 116: 841-848; advance online publication, March 7, 2017; 10.1038/bjc.2017.46

Abstract | Full Text

Clinical Studies

Top

Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomised controlled trial, the PEPs fatigue study

A Bourmaud, A Anota, C Moncharmont, F Tinquaut, M Oriol, V Trillet-Lenoir, A Bajard, S Parnalland, C Rotonda, F Bonnetain, D Pérol and F Chauvin

Br J Cancer 2017 116: 849-858; advance online publication, February 14, 2017; 10.1038/bjc.2017.31

Abstract | Full Text

Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial

S E Pinder, A F Campbell, J M S Bartlett, A Marshall, D Allen, M Falzon, J A Dunn, A Makris, L Hughes-Davies and R C Stein on behalf of OPTIMA Trial Management Group

Br J Cancer 2017 116: 859-863; advance online publication, February 21, 2017; 10.1038/bjc.2017.28

Abstract | Full Text

Patients’ perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey

Ulla-Sisko Lehto, Heli Tenhola, Kimmo Taari and Arpo Aromaa

Br J Cancer 2017 116: 864-873; advance online publication, February 21, 2017; 10.1038/bjc.2017.30

Abstract | Full Text

Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial

Roberto Pili, Glenn Liu, Sreenivasulu Chintala, Hendrick Verheul, Shabnam Rehman, Kristopher Attwood, Martin A Lodge, Richard Wahl, James I Martin, Kiersten Marie Miles, Silvia Paesante, Remi Adelaiye, Alejandro Godoy, Serina King, James Zwiebel and Michael A Carducci

Br J Cancer 2017 116: 874-883; advance online publication, February 21, 2017; 10.1038/bjc.2017.33

Abstract | Full Text

A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours

Richard H Wilson, TR Jeffry Evans, Mark R Middleton, L Rhoda Molife, James Spicer, Veronique Dieras, Patricia Roxburgh, Heidi Giordano, Sarah Jaw-Tsai, Sandra Goble and Ruth Plummer

Br J Cancer 2017 116: 884-892; advance online publication, February 21, 2017; 10.1038/bjc.2017.36

Abstract | Full Text

Translational Therapeutics

Top

PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype

Onofrio Antonio Catalano, Gary Lloyd Horn, Alberto Signore, Carlo Iannace, Maria Lepore, Mark Vangel, Angelo Luongo, Marco Catalano, Constance Lehman, Marco Salvatore, Andrea Soricelli, Ciprian Catana, Umar Mahmood and Bruce Robert Rosen

Br J Cancer 2017 116: 893-902; advance online publication, February 16, 2017; 10.1038/bjc.2017.26

Abstract | Full Text

Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells

Xin Liang, Haiyang Shi, Liyan Yang, Cen Qiu, Shengchao Lin, Yingxue Qi, Jiyu Li, Aiguang Zhao and Jianwen Liu

Br J Cancer 2017 116: 903-911; advance online publication, February 21, 2017; 10.1038/bjc.2017.32

Abstract | Full Text

Inhibition of Cdk5 induces cell death of tumor-initiating cells

Melanie M Mandl, Siwei Zhang, Melanie Ulrich, Elisa Schmoeckel, Doris Mayr, Angelika M Vollmar and Johanna Liebl

Br J Cancer 2017 116: 912-922; advance online publication, February 21, 2017; 10.1038/bjc.2017.39

Abstract | Full Text

Molecular Diagnostics

Top

Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer

Robert P Jones, Paul A Sutton, Jonathan P Evans, Rachel Clifford, Andrew McAvoy, James Lewis, Abigail Rousseau, Roger Mountford, Derek McWhirter and Hassan Z Malik

Br J Cancer 2017 116: 923-929; advance online publication, February 16, 2017; 10.1038/bjc.2017.37

Abstract | Full Text

Oncogenic role of PDK4 in human colon cancer cells

D Leclerc, D N T Pham, N Lévesque, M Truongcao, W D Foulkes, C Sapienza and R Rozen

Br J Cancer 2017 116: 930-936; advance online publication, February 16, 2017; 10.1038/bjc.2017.38

Abstract | Full Text

Intracrine androgen biosynthesis in renal cell carcinoma

Geun Taek Lee, Christopher S Han, Young Suk Kwon, Rutveej Patel, Parth K Modi, Seok Joo Kwon, Izak Faiena, Neal Patel, Eric A Singer, Han-Jong Ahn, Wun-Jae Kim and Isaac Y Kim

Br J Cancer 2017 116: 937-943; advance online publication, March 2, 2017; 10.1038/bjc.2017.42

Abstract | Full Text

Predicting the presence of colon cancer in members of a health maintenance organisation by evaluating analytes from standard laboratory records

Ran Goshen, Barak Mizrahi, Pini Akiva, Yaron Kinar, Eran Choman, Varda Shalev, Victoria Sopik, Revital Kariv and Steven A Narod

Br J Cancer 2017 116: 944-950; advance online publication, March 2, 2017; 10.1038/bjc.2017.53

Abstract | Full Text

Epidemiology

Top

Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies

Jessica L Petrick, Scott P Kelly, Linda M Liao, Neal D Freedman, Barry I Graubard and Michael B Cook

Br J Cancer 2017 116: 951-959; advance online publication, February 14, 2017; 10.1038/bjc.2017.29

Abstract | Full Text

Gestational diabetes mellitus may be associated with increased risk of breast cancer

Yong-Moon Mark Park, Katie M O'Brien, Shanshan Zhao, Clarice R Weinberg, Donna D Baird and Dale P Sandler

Br J Cancer 2017 116: 960-963; advance online publication, February 16, 2017; 10.1038/bjc.2017.34

Abstract | Full Text

Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer

Shana J Kim, Barry Rosen, Isabel Fan, Anna Ivanova, John R McLaughlin, Harvey Risch, Steven A Narod and Joanne Kotsopoulos

Br J Cancer 2017 116: 964-971; advance online publication, February 16, 2017; 10.1038/bjc.2017.35

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group